News
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
A report from the human resources trade group SHRM, which just released its 2025 Benefits Survey—the most comprehensive ...
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
For people who constantly think about what they are going to eat meal to meal, their food noise goes down significantly’ ...
The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results